Gene Query: PTPRD

Dataset Description Geneva Score
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 76.26
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 76.26
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 63.2
RNA sequencing of BT142 and TS603 cell lines 63.2
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 55.58
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp1] 55.05
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 52.78
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 52.0
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 50.47
Role of CD133 molecule in WNT response and renal repair 48.3
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 45.79
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 44.62
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 41.81
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 41.31
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 37.61
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 37.34
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 36.91
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 35.01
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 34.38
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 34.29
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 33.92
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 33.23
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 32.36
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 30.39
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 30.39
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 30.02
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 29.99
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 29.27
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 29.24
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 29.24
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 29.11
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 27.97
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 27.96
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 27.58
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 26.61
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 26.6
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 26.38
MEIS1 regulates hematopoiesis in hPSCs 26.35
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 26.23
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 26.13
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 26.01
DJ-1 is dispensable for human stem cell homeostasis 25.28
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 24.78
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 24.77
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 24.73
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 24.67
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 24.59
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 24.25
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 24.13
Spliceosomal disruption of the non-canonical BAF complex in cancer 24.0
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 23.78
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 23.64
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 23.57
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 23.44
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 23.08
Global expression profiles in cardiac progenitor cells generated by ISX-9 23.08
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 22.22
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 22.18
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 21.51
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 21.51
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 20.75
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 20.6
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 20.23
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 19.97
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 19.68
Lineage specific differentiation is influenced by state of human pluripotency 19.68
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 19.33
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 19.33
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 19.25
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 19.25
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 19.14
Epigenomic landscape during organ formation in human early embryos 18.82
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 18.14
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 18.07
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 18.06
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 17.86
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 17.86
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 17.55
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 17.27
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 17.11
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 17.02
Identifying the molecular mode of action of itraconazole in colorectal cancer 16.98
circRNA-sequencing 16.96
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 16.94
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 16.84
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 16.79
Functional astrocytes differentiated from hiPSCs 16.5
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 16.28
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 16.27
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 16.11
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 16.03
HNF1 regulates critical functions of the human epididymis epithelium. 16.03
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 16.02
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 15.95
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 15.84
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 15.74
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 15.58
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 15.57
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 15.41
Identification of Atrial Fibrillation associated genes and functional non-coding variants 15.39
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 15.3
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 15.3
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 15.22
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 15.19
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 15.0
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 14.5
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 14.34
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 14.34
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 14.06
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 13.92
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 13.89
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 13.89
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 13.82
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 13.8
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 13.77
Region-specific Innate Antiviral Responses of the Human Epididymis 13.7
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 13.66
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 13.53
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 13.36
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 13.32
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 13.31
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 13.31
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 13.1
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 13.01
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 12.91
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 12.91
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 12.9
Small-molecule targeting of brachyury transcription factor addiction in chordoma 12.8
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 12.8
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 12.78
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 12.75
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 12.64
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 12.45
Molecular analysis of renal cell carcinoma with unclassfied histology 12.45
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 12.41
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 12.31
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 12.28
MeRIP-seq for heat shock in B-cell lymphoma cells 12.2
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 12.06
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 12.01
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 12.01
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 11.87
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 11.77
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 11.75
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 11.75
Alteration of the microRNA network during the progression of Alzheimer’s disease 11.72
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 11.53
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 11.53
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 11.41
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 11.41
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 11.4
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 11.4
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 11.37
Dynamic reorganization of nuclear architecture during human cardiogenesis 11.37
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 11.37
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 11.35
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 11.35
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 11.2
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 11.16
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 11.11
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 10.93
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 10.93
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 10.9
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 10.85
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 10.82
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 10.77
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 10.71
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 10.66
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 10.66
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 10.61
Transcriptional dependencies in diffuse intrinsic pontine glioma 10.57
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 10.54
Zika infected neural stem cells 10.53
Transcriptome analysis of Zika infected neural stem cells 10.53
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 10.51
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 10.51
Neurofibroma 10.49
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 10.49
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 10.34
In vitro modeling of human germ cell development using pluripotent stem cells 10.31
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 10.3
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 10.3
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 10.25
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 10.25
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 10.18
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 10.12
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 10.11
Glioblastoma stem cells infected by ZIKA virus 10.1
AMPK signaling for naïve pluripotency [Hs] 10.05
AMPK signaling for naïve pluripotency 10.05
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 9.99
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 9.89
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 9.87
Effect of disulfiram treatment on pediatric high grade glioma 9.86
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 9.7
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 9.7
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 9.67
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 9.67
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 9.62
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 9.62
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 9.6
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 9.56
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 9.44
Total RNA sequencing of WT intestinal orgaonids. 9.44
Gene expression profile difference among renal location in a stone former 9.27
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 9.17
Gene profiling of human adult and pediatric liver cancer cells 9.13
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 9.12
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 9.12
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 9.02
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 8.85
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 8.81
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 8.79
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 8.77
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 8.76
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 8.76
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 8.75
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 8.75
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 8.71
Dissecting neural differentiation regulatory networks through epigenetic footprinting 8.66
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 8.64
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 8.64
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 8.61
Zika virus directly infects human peripheral neurons and induces cell death 8.59
Transcriptomic and gene ontology profiling of the human corneal cell types 8.55
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 8.47
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 8.43
Total RNA sequencing of APC mutant and wt colonic organoids 8.43
High-efficiency RNA-based reprogramming of human primary fibroblasts 8.41
Epigenome regulation during epidermal lineage commitment 8.36
Induced DNA demethylation, genome instability and transcription 8.26
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 8.26
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 8.23
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 8.23
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 8.06
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 8.06
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 7.97
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 7.95
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 7.95
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 7.85
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 7.82
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 7.75
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 7.7
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 7.62
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 7.62
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 7.6
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 7.58
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 7.53
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 7.52
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 7.51
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 7.47
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 7.44
Identification of long noncoding RNAs in T-ALL cell lines 7.34
LINE-2 transposable elements are a source of functional human microRNAs and target sites 7.34
Genome-wide identification of cancer-specific alternative splicing in circRNA 7.33
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 7.3
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 7.27
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 7.24
RNA-seq of naive and primed ES cells (NHSM) 7.23
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 7.21
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 7.15
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 7.15
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 7.11
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 7.1
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 7.07
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 7.04
Differential gene expression in Jagged1 treated human dental pulp cells. 7.0
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 6.98
Gene expressions of H9s in different culture systems 6.96
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 6.96
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 6.96
Gene expression of thyroid cancer cell lines 6.95
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 6.93
A Unique Epigenomic Landscape Defines Human Erythropoiesis 6.9
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 6.9
RNA-sequencing 6.77
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 6.76
Expression profiles of the four human major ectodermal lineages 6.76
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 6.75
Human optic chiasm from healthy controls and multiple sclerosis patients 6.72
Multiple sclerosis and EAE 6.72
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 6.69
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 6.68
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 6.66
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 6.63
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 6.53
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 6.46
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 6.44
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 6.43
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 6.31
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 6.3
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 6.29
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 6.26
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 6.23
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 6.23
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 6.2
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 6.16
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 6.15
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 6.15
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 6.13
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 6.08
Examining serotonergic neuron differentiation from human iPSCs 6.05
Universal alternative splicing of noncoding exons 6.03
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 6.0
Expression patterns in chronic thromboembolic pulmonary hypertension 5.92
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 5.92
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 5.9
Transcriptomes in healthy and CHB fetal hearts 5.86
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 5.84
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 5.82
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 5.77
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 5.77
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 5.75
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 5.6
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 5.57
Induction of Cardiomyocyte Proliferation [pz-822_human] 5.57
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 5.57
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 5.55
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 5.54
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 5.48
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 5.47
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 5.42
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 5.26
The Glioma-Infiltrating T Cell Receptor Repertoire 5.19
Subtle asymmetry of gene expression in embryonic and foetal human brains 5.05
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 5.04
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 5.03
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 5.03
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 5.01
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 5.01
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 4.79
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 4.75
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 4.72
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 4.72
Dynamic 3D chromosomal landscapes in acute leukemia 4.67
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 4.67
Global transcriptome analysis of HAP1 cells 4.66
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 4.57
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 4.55
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 4.55
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 4.5
Transcriptomic profile of human embryonic renal corpuscles 4.48
MYCL and EP400 are required for Max and MCPyV mediated gene activation 4.46
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 4.45
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 4.43
Primate-specific gene TMEM14B promotes cortical expansion and folding 4.35
Next Generation Sequencing of human SMA and healthy control Motor Neurons 4.31
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 4.27
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 4.26
FOXP2's impact on the primate transcriptome 4.2
Single-cell analysis of human kidney organoids 4.19
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 4.18
Derivation and differentiation of haploid human embryonic stem cells 4.17
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 4.16
CUREfast: Accelerating research with families 4.16
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 4.14
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 4.02
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 4.02
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 3.95
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 3.95
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 3.95
Gene expression in GBM with Cav3.2 inhibition 3.94
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 3.91
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 3.88
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 3.7
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 3.63
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 3.62
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 3.58
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 3.58
mRNA-Seq profiling of human developing kidney 3.58
Leucegene: ALL sequencing 3.55
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 3.53
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 3.51
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 3.35
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 3.33
Deep RNA sequencing of the human placental transcriptome 3.27
RNA-seq of SCLC PDX models treated with EP 3.19
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 3.17
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 3.17
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 3.11
Measure transcript integrity using RNA-seq data 3.04
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 3.0
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 2.98
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 2.98
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 2.97
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 2.97
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 2.96
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 2.86
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 2.85
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 2.77
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 2.77
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 2.74
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 2.72
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 2.67
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 2.6
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 2.58
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 2.57
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 2.5
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 2.49
Repurposing of promoters and enhancers during mammalian evolution 2.46
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 2.33
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 2.33
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 2.33
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 2.3
iPSC-Derived Cholangiocytes 2.22
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 2.14
Non-coding regions are the main source of tumor-specific antigens 2.13
Non-coding regions are the main source of tumor-specific antigens [human] 2.13
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 2.1
RNAseq of Breast cancer PDX samples 2.09
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 2.05
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 1.97
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 1.96
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 1.95
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 1.73
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 1.7
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 1.67
RNA-sequencing of human tendon after injury 1.66
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 1.63
Widespread regulated alternative splicing of single codons accelerates proteome evolution 1.59
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 1.59
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 1.57
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 1.57
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 1.54
Gene expression of collecting duct carcinoma of the kidney 1.51
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 1.48
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 1.48
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 1.48
Identification of expressed and conserved human non-coding RNAs 1.43
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 1.39
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 1.39
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 1.39
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 1.34
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 1.32
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 1.31
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 1.29
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 1.26
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 1.26
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 1.24
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 1.23
Entrectinib Resistance in a Neuroblastoma Xenograft Model 1.21
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 1.19
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 1.18
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 1.17
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 1.17
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 1.15
Bone marrow derived human B cells [normal proB] 1.14
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 1.13
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 1.12
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 1.11
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 1.1
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 1.09
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 1.05
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 1.04
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 1.02
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 0.95
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 0.95
RNA splicing alteration on glioblastoma and normal neural stem cells 0.93
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 0.91
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.9
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.81
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.79
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 0.72
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.71
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 0.7
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.62
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 0.61
RNA-seq of stable and unstable section of human atherosclerotic plaques 0.59
RNA-seq in endometrial stromal tumors 0.52
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 0.49
RNA sequencing of T-ALL (COG study) 0.49
Analyses of T-ALL (COG study) 0.49
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 0.47
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.46
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.45
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.36
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 0.36
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 0.36
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 0.33
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 0.32
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 0.32
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 0.3
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.28
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.28
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.27
Global transcriptome analysis of WT versus HEB-/- hESCs 0.23
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 0.23
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.19
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.18
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 0.16
DAOY-Notch1/Notch2 knockout: transcriptome comparison 0.15
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.13
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.13
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 0.12
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 0.09
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.07
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 0.04
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.03
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.03
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation